Contract Pharma Manufacturing Solutions
-
Comprehensive Manufacturing Solutions Backed By Global Expertise
8/4/2025
Gain insight into a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance that can support your company's needs.
-
High-Speed Filling Line For Vials
9/1/2023
Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.
-
Improving CLD Efficiency With An Innovative Platform
Cell line development (CLD) bottlenecks can stall progress on the path to clinical trials. Examine how a novel CLD platform can accelerate development for efficient protein and vaccine production.
-
An End-To-End Partner From Concept To Clinic
12/15/2025
Explore the full scope of integrated services spanning multiple advanced therapy modalities, development, and GMP manufacturing. Flexible engagement models support programs from concept to clinic.
-
Energy And Specialty Chemistry Solutions
Safely scale the production of APIs using highly energetic chemistry, backed by decades of expertise, controlled processes, and CGMP-compliant conditions from development to commercial manufacturing.
-
Leveraging An Innovative Conjugation Technology For Better ADCs
Learn how an advanced conjugation technology can provide a more uniform DAR profile, enhanced linker stability, and improved pharmacokinetic properties, paving the way for more efficacious ADCs.
-
Your Sterile Partner Of Choice.
10/16/2024
Aseptic and terminally sterilized manufacturing of biologics and small molecule drug products for parenteral, ocular, and pulmonary delivery.
-
Integrated Vector Production Capabilities
10/29/2019
From products and services to complete manufacturing offerings, find out how MilliporeSigma can help you produce better, faster viral vectors.
-
Accelerated Antibody Production
12/20/2021
Wherever your company is in its evolution, AGC Biologics can deliver at least 500 grams of monoclonal antibody manufactured under cGMP.
-
Small Is Powerful, Small Is Green
As the pharmaceutical industry innovates and evolves, learn more about how Nanoform can play a critical role in empowering your company's journey to net zero.